Does Patriot Scientific stock pay a dividend?
Patriot Scientific does not currently pay a dividend. Patriot Scientific does not have a long track record of dividend growth. In the past three months, Patriot Scientific insiders have not sold or bought any company stock. Only 0.96% of the stock of Patriot Scientific is held by insiders.
What does the merger of Patriot technologies mean for investors?
The merged company will focus on advancing its immunotherapy pipeline of products including intra-tumoral immunotherapy of cancer and its modular vaccine platform. "Patriot was able to create substantial shareholder value for many years through licensing of our broad microprocessor intellectual property patents.
What other companies does Patriot Scientific own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Patriot Scientific investors own include Co-Diagnostics (CODX), PharmaCyte Biotech (PMCB), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Al...
What is Patriot scientific's mailing address?
Patriot Scientific's mailing address is 2038 CORTE DEL NOGAL SUITE 141, CARLSBAD CA, 92011. The technology company can be reached via phone at 760-795-8517 or via email at [email protected].
Who are Patriot Scientific's key executives?
Patriot Scientific's management team includes the following people: Mr. Steven W. King , Pres, CEO & Director (Age 56) Mr. Paul J. Lytle , Exec...
Who are some of Patriot Scientific's key competitors?
Some companies that are related to Patriot Scientific include Dolby Laboratories (DLB) , Digital Turbine (APPS) , InterDigital (IDCC) , Franchi...
What other stocks do shareholders of Patriot Scientific own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Patriot Scientific investors own include Co-Diagnostics (C...
What is Patriot Scientific's stock symbol?
Patriot Scientific trades on the OTCMKTS under the ticker symbol "PTSC."
How do I buy shares of Patriot Scientific?
Shares of PTSC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Patriot Scientific's stock price today?
One share of PTSC stock can currently be purchased for approximately $1.44.
How many employees does Patriot Scientific have?
Patriot Scientific employs 1 workers across the globe.
What is Patriot Scientific's official website?
The official website for Patriot Scientific is www.ptsc.com .
How can I contact Patriot Scientific?
Patriot Scientific's mailing address is 2038 CORTE DEL NOGAL SUITE 141, CARLSBAD CA, 92011 . The technology company can be reached via phone at 7...
What is the new Patriot Scientific name?
NOVATO, CA / ACCESSWIRE / December 1, 2020 / Patriot Scientific Corporation ("Patriot") (OTC PINK:PTSC) announced today that it has changed its name to "Mosaic ImmunoEngineering Inc.", (the "Company" or "Mosaic") effective immediately. In addition, the Company will change its stock symbol on the OTC Market to "CPMV" as described below and will effect a reverse stock split at a ratio of 1-for-500 (the "Reverse Stock Split") anticipated to be effective on or about December 2, 2020 (the "Effective Date"), at which time, the Company's common stock will trade thereafter on a post-split adjusted basis. The Company's corporate website is located at www.mosaicie.com.
What is the CUSIP number for a reverse stock split?
On the Effective Date of the Reverse Stock Split, the CUSIP number of our common stock will change to 61945M101.
How many shares were reduced in the reverse stock split?
In connection with the Reverse Stock Split, the number of authorized shares of common stock was reduced from 600,000,000 shares to 100,000,000 shares.
What is reverse stock split?
The Reverse Stock Split will reduce the number of fully diluted shares of the Company's common stock currently issued and outstanding, including the number of shares issuable upon the conversion of Series A and Series B Convertible Voting Preferred Stock, from approximately 4 billion shares to approximately 8 million shares. Every 500 outstanding shares of common stock, which are outstanding on the anticipated effective date of December 2, 2020, will be combined into and automatically become one (1) outstanding share of common stock of the Company without increasing or decreasing the par value of each share of common stock. No fractional share will be issued in connection with the foregoing combination of the shares pursuant to the Reverse Stock Split. Instead, the Company will issue to the Company's stockholders holding a fractional share of common stock one (1) additional share of common stock for each fractional share. Each stockholder's percentage ownership interest in the Company and proportional voting power remains virtually unchanged as a result of the Reverse Stock Split, except for minor changes and adjustments that will result from rounding fractional shares into whole shares.
What is the merger of Mosaic and Patriot?
The merger is structured as a stock-for-stock transaction whereby all of Mosaic's outstanding shares of Class A and Class B common stock will be exchanged for Patriot's Series A and Series B Preferred Stock. A subsidiary of Patriot will buy from the stockholders of Mosaic 630,000 shares of its Class A common stock and 70,000 shares of its Class B common stock, representing 100% of the issued and outstanding common stock of Mosaic, in exchange for 630,000 shares of the Patriot's Series A Convertible Preferred Stock ("Series Preferred") and 70,000 shares of Patriot's Series B Convertible Preferred Stock ("Series B preferred), respectively. Each share of the Series A Preferred; shall (a) convert into 5,097.053 shares of common stock of the Parent, (b) possess full voting rights, on an as-converted basis, as the common stock of the Parent, and (c) have no dividend rate. Each share of the Series B Preferred; shall (a) convert into 5,734.185 shares of common stock of the Parent, (b) possess full voting rights, on an as-converted basis, as the common stock of the Parent, (c) have no dividend rate, and (d) shall possess certain anti-dilution protections as defined in the Series B Certificate of Designations. On a fully diluted, as converted basis, it is anticipated that Patriot's equityholders immediately prior to the merger will own 10% of the combined company and Mosaic's equityholders immediately prior to the merger will own 90% of the combined company.
Does Patriot have any obligation to update forward-looking statements?
Except as otherwise required by law, Patriot disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether, as a result of new information, future events or circumstances or otherwise. Loading...